1. ALLA AKTIER
  2. NYHETER
  3. LÄRKBERGET

Lärkberget

Nyheter Lärkberget Nyheter alla bolag
Slipp dessa annonser och få en massa andra godsaker med vårt premiumabonnemang.

Clarification regarding the management's role during the restructuring period

MARKN.

CombiGene AB (publ) (“CombiGene”, the “Company”) would like to clarify this morning's memo by stating that the current CEO and management will remain in their roles during the notice period. During this time, the board is working to ensure a management structure that is adapted to the company's future needs.

Contacts

CombiGene AB (publ)
Luca Di Stefano, Chairman of the Board
Phone: +46 (0)70 855 67 23
luca.distefano@combigene.com

www.combigene.com
CombiGene AB (publ), Skeppsbron 38, SE-111 30 Stockholm, Sweden
+46-8-357355 info@combigene.com

About CombiGene

The company is public and listed on the Swedish marketplace Nasdaq First North Growth Market and the company’s Certified Advisor is Västra Hamnen Corporate Finance AB.

Attachments

Clarification regarding the management's role during the restructuring period

Datum 2025-01-09, kl 15:50
Källa MFN
Bifogade filer
Clarification regarding the management's role during the restructuring period